comparison of daily symptoms , twice daily peak expiratory flow rate ( pefr ) , and use of salbutamol during the 2 months of the trial showed that control of asthma was equally good , irrespective of the device used to deliver active beclomethasone .
C0001927
salbutamol
C0004096
asthma